vs
Enovis CORP（ENOV）与Hamilton Insurance Group, Ltd.（HG）财务数据对比。点击上方公司名可切换其他公司
Hamilton Insurance Group, Ltd.的季度营收约是Enovis CORP的1.3倍（$728.3M vs $548.9M），Hamilton Insurance Group, Ltd.净利率更高（29.5% vs -104.1%，领先133.5%），Hamilton Insurance Group, Ltd.同比增速更快（27.7% vs -2.2%），过去两年Enovis CORP的营收复合增速更高（9.8% vs 5.2%）
Enovis是一家专注于骨科领域的医疗科技企业，其前身是1995年由米切尔·雷尔斯和史蒂文·雷尔斯兄弟创立的科尔法克斯公司。公司总部位于特拉华州威尔明顿，目前在全球12个地点开展业务，拥有超过5000名员工，于纽约证券交易所上市，股票代码为ENOV。
汉密尔顿保险集团有限公司是一家多元化的保险及相关金融服务控股公司，总部位于百慕大汉密尔顿。公司于1999年10月25日从美国特拉华州迁册至此，主要通过旗下保险子公司及其他关联机构开展核心业务，业务布局覆盖多元保险服务场景。
ENOV vs HG — 直观对比
营收规模更大
HG
是对方的1.3倍
$548.9M
营收增速更快
HG
高出29.8%
-2.2%
净利率更高
HG
高出133.5%
-104.1%
两年增速更快
ENOV
近两年复合增速
5.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $548.9M | $728.3M |
| 净利润 | $-571.1M | $214.6M |
| 毛利率 | 59.9% | — |
| 营业利润率 | -101.7% | 26.0% |
| 净利率 | -104.1% | 29.5% |
| 营收同比 | -2.2% | 27.7% |
| 净利润同比 | 18.8% | 188.3% |
| 每股收益（稀释后） | $-9.99 | $1.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENOVHG
| Q4 25 | $548.9M | $728.3M | ||
| Q3 25 | $564.5M | $667.6M | ||
| Q2 25 | $558.8M | $740.8M | ||
| Q1 25 | — | $768.8M | ||
| Q4 24 | $561.0M | $570.5M | ||
| Q3 24 | $505.2M | $512.8M | ||
| Q2 24 | $525.2M | $587.9M | ||
| Q1 24 | $516.3M | $658.6M |
净利润ENOVHG
| Q4 25 | $-571.1M | $214.6M | ||
| Q3 25 | $-36.7M | $176.4M | ||
| Q2 25 | $-56.0M | $267.8M | ||
| Q1 25 | — | $181.3M | ||
| Q4 24 | $-703.2M | $74.4M | ||
| Q3 24 | $-31.5M | $61.0M | ||
| Q2 24 | $-18.6M | $200.4M | ||
| Q1 24 | $-72.0M | $277.3M |
毛利率ENOVHG
| Q4 25 | 59.9% | — | ||
| Q3 25 | 59.3% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 54.8% | — | ||
| Q3 24 | 56.7% | — | ||
| Q2 24 | 55.0% | — | ||
| Q1 24 | 57.7% | — |
营业利润率ENOVHG
| Q4 25 | -101.7% | 26.0% | ||
| Q3 25 | -3.0% | 27.0% | ||
| Q2 25 | -8.4% | 36.5% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | -118.5% | 13.4% | ||
| Q3 24 | -6.3% | 12.5% | ||
| Q2 24 | -8.4% | 34.5% | ||
| Q1 24 | -6.8% | 42.2% |
净利率ENOVHG
| Q4 25 | -104.1% | 29.5% | ||
| Q3 25 | -6.5% | 26.4% | ||
| Q2 25 | -10.0% | 36.1% | ||
| Q1 25 | — | 23.6% | ||
| Q4 24 | -125.4% | 13.0% | ||
| Q3 24 | -6.2% | 11.9% | ||
| Q2 24 | -3.5% | 34.1% | ||
| Q1 24 | -13.9% | 42.1% |
每股收益（稀释后）ENOVHG
| Q4 25 | $-9.99 | $1.67 | ||
| Q3 25 | $-0.64 | $1.32 | ||
| Q2 25 | $-0.98 | $1.79 | ||
| Q1 25 | — | $0.77 | ||
| Q4 24 | $-12.69 | $0.35 | ||
| Q3 24 | $-0.58 | $0.74 | ||
| Q2 24 | $-0.34 | $1.20 | ||
| Q1 24 | $-1.32 | $1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.6M | $1.1B |
| 总债务越低越好 | $1.4B | $149.7M |
| 股东权益账面价值 | $2.0B | $2.8B |
| 总资产 | $4.4B | $9.6B |
| 负债/权益比越低杠杆越低 | 0.67× | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资ENOVHG
| Q4 25 | $33.6M | $1.1B | ||
| Q3 25 | $44.1M | $955.1M | ||
| Q2 25 | $38.5M | $985.6M | ||
| Q1 25 | — | $838.5M | ||
| Q4 24 | $48.2M | $996.5M | ||
| Q3 24 | $35.4M | $957.4M | ||
| Q2 24 | $35.0M | $1.0B | ||
| Q1 24 | $66.3M | $1.1B |
总债务ENOVHG
| Q4 25 | $1.4B | $149.7M | ||
| Q3 25 | $1.4B | $149.7M | ||
| Q2 25 | $1.4B | $149.7M | ||
| Q1 25 | — | $150.0M | ||
| Q4 24 | $1.3B | $149.9M | ||
| Q3 24 | $1.3B | $149.9M | ||
| Q2 24 | $1.3B | $149.9M | ||
| Q1 24 | $1.3B | $149.9M |
股东权益ENOVHG
| Q4 25 | $2.0B | $2.8B | ||
| Q3 25 | $2.6B | $2.7B | ||
| Q2 25 | $2.6B | $2.6B | ||
| Q1 25 | — | $2.4B | ||
| Q4 24 | $2.6B | $2.3B | ||
| Q3 24 | $3.3B | $2.3B | ||
| Q2 24 | $3.3B | $2.2B | ||
| Q1 24 | $3.3B | $2.2B |
总资产ENOVHG
| Q4 25 | $4.4B | $9.6B | ||
| Q3 25 | $5.0B | $9.2B | ||
| Q2 25 | $4.9B | $8.9B | ||
| Q1 25 | — | $8.3B | ||
| Q4 24 | $4.7B | $7.8B | ||
| Q3 24 | $5.6B | $7.8B | ||
| Q2 24 | $5.4B | $7.6B | ||
| Q1 24 | $5.5B | $7.3B |
负债/权益比ENOVHG
| Q4 25 | 0.67× | 0.05× | ||
| Q3 25 | 0.54× | 0.06× | ||
| Q2 25 | 0.53× | 0.06× | ||
| Q1 25 | — | 0.06× | ||
| Q4 24 | 0.52× | 0.06× | ||
| Q3 24 | 0.40× | 0.06× | ||
| Q2 24 | 0.41× | 0.07× | ||
| Q1 24 | 0.40× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.6M | $293.4M |
| 自由现金流经营现金流 - 资本支出 | $29.1M | — |
| 自由现金流率自由现金流/营收 | 5.3% | — |
| 资本支出强度资本支出/营收 | 9.7% | — |
| 现金转化率经营现金流/净利润 | — | 1.37× |
| 过去12个月自由现金流最近4个季度 | $22.8M | — |
8季度趋势，按日历期对齐
经营现金流ENOVHG
| Q4 25 | $82.6M | $293.4M | ||
| Q3 25 | $47.8M | $295.6M | ||
| Q2 25 | $-1.6M | $218.4M | ||
| Q1 25 | — | $34.9M | ||
| Q4 24 | $88.3M | $284.1M | ||
| Q3 24 | $53.6M | $160.6M | ||
| Q2 24 | $7.8M | $156.4M | ||
| Q1 24 | $-36.2M | $158.2M |
自由现金流ENOVHG
| Q4 25 | $29.1M | — | ||
| Q3 25 | $3.4M | — | ||
| Q2 25 | $-44.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $35.1M | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $-31.6M | — | ||
| Q1 24 | $-73.1M | — |
自由现金流率ENOVHG
| Q4 25 | 5.3% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -8.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | -6.0% | — | ||
| Q1 24 | -14.2% | — |
资本支出强度ENOVHG
| Q4 25 | 9.7% | — | ||
| Q3 25 | 7.9% | — | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 10.1% | — | ||
| Q2 24 | 7.5% | — | ||
| Q1 24 | 7.2% | — |
现金转化率ENOVHG
| Q4 25 | — | 1.37× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 3.82× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |
HG
暂无分部数据
